Canada Spends Logo

Explorez notre analyse du budget 2026

Grant: Master's Award: Canada Graduate Scholarships

University of Calgary

$17,500.00

Anti-Müllerian Hormone and Cardiovascular Risk in Males with Chronic Kidney Disease

EF 2022-23

Résumé
One in 8 Canadian males have Chronic Kidney Disease (CKD), and the prevalence is increasing. Cardiovascular disease is the leading cause of death in individuals with CKD, and males are at increased risk compared to females. Prevention and treatment of cardiovascular disease has been identified as one of the top 10 research priorities by people living with CKD in Canada. Male sex hormones play an important role in cardiovascular risk, and males living with CKD have unbalanced sex hormones compared to their healthy counterparts. Reduced sex hormone levels, especially anti-mullerian hormone (AMH), have been associated with increased cardiovascular risk in the general population and in females with CKD, but it is yet unknown whether reduced AMH in males with kidney disease is associated with an increased risk of cardiovascular disease. This study aims to examine the relationship between AMH and cardiovascular risk in males living with CKD. A cross sectional study of 73 males with CKD will be undertaken in Calgary, Alberta. Demographic and medical information will be collected from each participant to examine their current cardiovascular health. AMH levels will be collected with a single blood draw. Vascular health measurements, validated markers of future cardiovascular disease risk, will be acquired using a previously published protocol. The relationship between AMH and vascular health outcomes will be analyzed. Cardiovascular disease is the leading cause of death in Canadian males with CKD, and strategies for early detection and prevention are urgently warranted. The results of this study will help to provide insight into cardiovascular risk in males with kidney disease and may be used for cardiovascular risk prediction or future treatment targets.
Programme
Master's Award: Canada Graduate Scholarships
Bénéficiaire
Emplacement
Alberta, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database

Tel que publié

Id
485991
Name
Larsen Nicole
Region
Alberta
Country
Canada
Orgtype
Institution Paid; Research Institution
Prcname2
Special Cases - Awards Programs
Projecttitle
Anti-Müllerian Hormone and Cardiovascular Risk in Males with Chronic Kidney Disease
Programtype2
Studentship Programs
Orgnameinp2
University of Calgary
Cihramount2
$17,500
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Scholarships
Keyworddelim
Anti-Mullerian Hormone; Arterial Stiffness; Cardiovascular; Kidney Disease; Men'S Health; Pulse Wave Velocity; Reproductive Health; Sex Hormones
Abstract
One in 8 Canadian males have Chronic Kidney Disease (CKD), and the prevalence is increasing. Cardiovascular disease is the leading cause of death in individuals with CKD, and males are at increased risk compared to females. Prevention and treatment of cardiovascular disease has been identified as one of the top 10 research priorities by people living with CKD in Canada. Male sex hormones play an important role in cardiovascular risk, and males living with CKD have unbalanced sex hormones compared to their healthy counterparts. Reduced sex hormone levels, especially anti-mullerian hormone (AMH), have been associated with increased cardiovascular risk in the general population and in females with CKD, but it is yet unknown whether reduced AMH in males with kidney disease is associated with an increased risk of cardiovascular disease. This study aims to examine the relationship between AMH and cardiovascular risk in males living with CKD. A cross sectional study of 73 males with CKD will be undertaken in Calgary, Alberta. Demographic and medical information will be collected from each participant to examine their current cardiovascular health. AMH levels will be collected with a single blood draw. Vascular health measurements, validated markers of future cardiovascular disease risk, will be acquired using a previously published protocol. The relationship between AMH and vascular health outcomes will be analyzed. Cardiovascular disease is the leading cause of death in Canadian males with CKD, and strategies for early detection and prevention are urgently warranted. The results of this study will help to provide insight into cardiovascular risk in males with kidney disease and may be used for cardiovascular risk prediction or future treatment targets.
Competitiondate
202212
Approvedterm2
1 yr 0 mth
Pinamesdelim
Larsen, Nicole
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $17,500~ $0~